Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | AGEN Agenus Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $7.85 +8.7% | $15.06 -2.0% |
| StockIQ Score | 54C- Moderate Risk: High | 36F Weak Risk: Medium |
| Technical | 65B- | 13F |
| Fundamental | 34F | 35F |
| Growth | 79B+ | 50C- |
| Fair Value | 38F | 38F |
| News | 50C- | 50C- |
| Quality | 63C+ | 50C- |
| Risk | 32F | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Agenus (AGEN) outperforms Ascentage Pharma (AAPG) in technical (73 vs. 18) and growth (79 vs. 50) scores, showing stronger market trends and expansion potential. Both share similar valuation scores (38), but Agenus has a higher investor score (57 vs. 37) and a more favorable "MODERATE" rating compared to AAPG’s "WEAK." Fundamental scores are nearly equal (34 vs. 35).